600613.SS SHH
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.
1W: -13.2%
1M: -26.6%
3M: +74.3%
YTD: +25.8%
1Y: +17.5%
3Y: +27.2%
5Y: +67.1%
¥8.19 ($1.22)
+0.08 (+0.99%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$3.1B
-5.0% ▼
5Y CAGR: -2.6%
Total Liabilities
$689M
-22.5% ▼
5Y CAGR: -5.1%
Shareholders Equity
$2.4B
+1.2% ▲
5Y CAGR: -2.0%
Cash & Investments
$800M
+8.7% ▲
5Y CAGR: +6.1%
Total Debt
$167M
-34.0% ▼
5Y CAGR: -16.1%
Net Debt
-$612M
-32.5% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $481M | $494M | $656M | $715M | $779M |
| Short-Term Investments | $0 | $0 | $0 | $21M | $21M |
| Cash & ST Investments | $481M | $494M | $656M | $736M | $800M |
| Net Receivables | $682M | $695M | $824M | $760M | $534M |
| Inventory | $204M | $205M | $219M | $243M | $228M |
| Other Current Assets | $93M | $71M | $81M | $7M | $11M |
| Total Current Assets | $1.4B | $1.4B | $1.8B | $1.8B | $1.6B |
| Property, Plant & Equip. | $960M | $1.2B | $1.1B | $1.1B | $1.1B |
| Goodwill & Intangibles | $410M | $404M | $398M | $339M | $340M |
| Long-Term Investments | $98M | $94M | $80M | $82M | $66M |
| Other Non-Current Assets | $149M | $10M | $2M | $6M | $36M |
| Total Non-Current Assets | $1.7B | $1.7B | $1.6B | $1.5B | $1.5B |
| Total Assets | $3.1B | $3.1B | $3.4B | $3.3B | $3.1B |
| — Liabilities — | |||||
| Accounts Payable | $151M | $188M | $187M | $250M | $224M |
| Short-Term Debt | $3M | $3M | $21M | $55M | $27M |
| Deferred Revenue | $244M | $230M | $83M | $30M | $0 |
| Other Current Liabilities | $60M | $244M | $484M | $306M | $137M |
| Total Current Liabilities | $457M | $480M | $774M | $686M | $531M |
| Long-Term Debt | $286M | $243M | $208M | $170M | $130M |
| Other Non-Current Liab. | $18M | $0 | -$13M | $1M | $0 |
| Total Non-Current Liabilities | $313M | $277M | $234M | $203M | $158M |
| Total Liabilities | $770M | $756M | $1.0B | $889M | $689M |
| — Equity — | |||||
| Common Stock | $534M | $534M | $534M | $534M | $534M |
| Retained Earnings | $677M | $747M | $736M | $739M | $752M |
| Accumulated OCI | $241M | $239M | $233M | $238M | $252M |
| Total Stockholders Equity | $2.3B | $2.3B | $2.3B | $2.3B | $2.4B |
| Total Liabilities & Equity | $3.1B | $3.1B | $3.4B | $3.3B | $3.1B |
| — Key Metrics — | |||||
| Total Debt | $344M | $312M | $286M | $253M | $167M |
| Net Debt | -$138M | -$182M | -$371M | -$462M | -$612M |
| Total Investments | $98M | $94M | $80M | $103M | $87M |